Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 4, 2001, Pages 239-240

  Wagner, J L ^a   Flowers, M E D ^a   Longton, G ^a   Storb, R ^a   Martin, P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOSPORIN; IMMUNOGLOBULIN G; METHOTREXATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOPSY; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; FATALITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; LETTER; LIP; MORTALITY; PREDICTION; RISK ASSESSMENT; SCREENING; SKIN BIOPSY; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0035041462     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.abbmt070239     Document Type: Letter

References (4)